Beckman Coulter Acquires Siemens Healthcare Diagnostics’ Clinical Microbiology Business

Beckman Coulter (Brea, CA, USA), an indirect wholly-owned subsidiary of Danaher Corp. (Washington DC, MD, USA) has entered into a definitive agreement to purchase the clinical microbiology business of Siemens Healthcare Diagnostics (Chicago, IL, USA). The transaction is expected to close in the first quarter of 2015. The agreement is subject to applicable regulatory approvals and other customary closing conditions.

The Siemens clinical microbiology business is a leader in microbial identification and antibiotic sensitivity testing (ID/AST). The business operates with a base of over 6,000 instruments globally. The microbiology product line includes the MicroScanInstruments and MicroScan panels/consumables, along with data management solutions. The MicroScan systems are known for accuracy and detection of emerging resistance.

Beckman Coulter diagnostics president Arndt Kaldowski said, "The clinical microbiology business will be an excellent complement to Beckman Coulter's Diagnostics business with a strong reputation and market position. Adding its ID/AST solutions to our existing products and services will create an opportunity to enhance our offerings to laboratory customers and improve patient care. The acquisition expands our product portfolio with differentiated analytical systems and menu that elevate our clinical capabilities for customers, while driving continued growth."

Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. The company is dedicated to providing solutions to laboratories of all sizes––offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, automation, and information systems. For further information about the company see www.beckman-coulter.com.

Related Links:

Beckman Coulter

Danaher Corp.

Siemens Healthcare Diagnostics